To more generally explore the expression pattern of BRDT in cancer, we leveraged data from The Cancer Genome Atlas (TCGA) consortium and observed that BRDT is significantly expressed in several malignancies in addition to esophageal cancer and testicular cancer, including breast, lung, and head and neck cancers (Fig. 1B). Here, BRDT is linked to head and neck cancer.